284 related articles for article (PubMed ID: 38736891)
1. CD44: a cancer stem cell marker and therapeutic target in leukemia treatment.
Wu S; Tan Y; Li F; Han Y; Zhang S; Lin X
Front Immunol; 2024; 15():1354992. PubMed ID: 38736891
[TBL] [Abstract][Full Text] [Related]
2. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
3. CD44: More than a mere stem cell marker.
Morath I; Hartmann TN; Orian-Rousseau V
Int J Biochem Cell Biol; 2016 Dec; 81(Pt A):166-173. PubMed ID: 27640754
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan-CD44 interactions as potential targets for cancer therapy.
Misra S; Heldin P; Hascall VC; Karamanos NK; Skandalis SS; Markwald RR; Ghatak S
FEBS J; 2011 May; 278(9):1429-43. PubMed ID: 21362138
[TBL] [Abstract][Full Text] [Related]
5. CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches.
Williams K; Motiani K; Giridhar PV; Kasper S
Exp Biol Med (Maywood); 2013 Mar; 238(3):324-38. PubMed ID: 23598979
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.
Bourguignon LY; Shiina M; Li JJ
Adv Cancer Res; 2014; 123():255-75. PubMed ID: 25081533
[TBL] [Abstract][Full Text] [Related]
7. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
8. CD44 standard and CD44v10 isoform expression on leukemia cells distinctly influences niche embedding of hematopoietic stem cells.
Erb U; Megaptche AP; Gu X; Büchler MW; Zöller M
J Hematol Oncol; 2014 Mar; 7():29. PubMed ID: 24684724
[TBL] [Abstract][Full Text] [Related]
9. CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers.
Olsson E; Honeth G; Bendahl PO; Saal LH; Gruvberger-Saal S; Ringnér M; Vallon-Christersson J; Jönsson G; Holm K; Lövgren K; Fernö M; Grabau D; Borg A; Hegardt C
BMC Cancer; 2011 Sep; 11():418. PubMed ID: 21957977
[TBL] [Abstract][Full Text] [Related]
10. The Role of CD44 and Cancer Stem Cells.
Wang L; Zuo X; Xie K; Wei D
Methods Mol Biol; 2018; 1692():31-42. PubMed ID: 28986884
[TBL] [Abstract][Full Text] [Related]
11. CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells.
Zöller M
Front Immunol; 2015; 6():235. PubMed ID: 26074915
[TBL] [Abstract][Full Text] [Related]
12. CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer.
Hao JL; Cozzi PJ; Khatri A; Power CA; Li Y
Curr Cancer Drug Targets; 2010 May; 10(3):287-306. PubMed ID: 20370680
[TBL] [Abstract][Full Text] [Related]
13. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer.
Wang C; Xie J; Guo J; Manning HC; Gore JC; Guo N
Oncol Rep; 2012 Oct; 28(4):1301-8. PubMed ID: 22895640
[TBL] [Abstract][Full Text] [Related]
15. TGF-β1 promotes epithelial-to-mesenchymal transition and stemness of prostate cancer cells by inducing PCBP1 degradation and alternative splicing of CD44.
Chen Q; Gu M; Cai ZK; Zhao H; Sun SC; Liu C; Zhan M; Chen YB; Wang Z
Cell Mol Life Sci; 2021 Feb; 78(3):949-962. PubMed ID: 32440711
[TBL] [Abstract][Full Text] [Related]
16. Role of MAML1 in targeted therapy against the esophageal cancer stem cells.
Moghbeli M; Mosannen Mozaffari H; Memar B; Forghanifard MM; Gholamin M; Abbaszadegan MR
J Transl Med; 2019 Apr; 17(1):126. PubMed ID: 30992079
[TBL] [Abstract][Full Text] [Related]
17. Screening of peptides bound to breast cancer stem cell specific surface marker CD44 by phage display.
Park HY; Lee KJ; Lee SJ; Yoon MY
Mol Biotechnol; 2012 Jul; 51(3):212-20. PubMed ID: 21979823
[TBL] [Abstract][Full Text] [Related]
18. CD44: structure, function, and association with the malignant process.
Naor D; Sionov RV; Ish-Shalom D
Adv Cancer Res; 1997; 71():241-319. PubMed ID: 9111868
[TBL] [Abstract][Full Text] [Related]
19. CD44 standard isoform is involved in maintenance of cancer stem cells of a hepatocellular carcinoma cell line.
Asai R; Tsuchiya H; Amisaki M; Makimoto K; Takenaga A; Sakabe T; Hoi S; Koyama S; Shiota G
Cancer Med; 2019 Feb; 8(2):773-782. PubMed ID: 30636370
[TBL] [Abstract][Full Text] [Related]
20. A CD44v
Hu J; Li G; Zhang P; Zhuang X; Hu G
Cell Death Dis; 2017 Mar; 8(3):e2679. PubMed ID: 28300837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]